The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 4 | — | 20.8x | Bottom tier | |
Growth | 62 | -13.7% | 6.1% | Around median | |
Quality | 82 | 127.5% | 6.6% | Top tier | |
Safety | 36 | — | 0.7x | Bottom tier | |
Capital Return | 80 | — | 2.02% | Top tier | |
Momentum | 84 | 124.4% | 4.1% | Top tier | |
Sentiment | 43 | 6 | 3 | Around median |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Core Scientific, Inc. (CORZ) is building a high-density digital infrastructure platform aimed at the most demanding computing workloads, and is currently focused on data centers dedicated to artificial intelligence and high-performance computing rather than its previous reliance on Bitcoin mining. The revenue model is shifting toward high-density leasing and hosting, especially through the CoreWeave contracts whose revenue is recognized for accounting purposes on a straight-line basis over a 12-year lease term, while the Bitcoin mining business is being managed down to help offset contracted power costs during the transition period.
In the first quarter of fiscal 2026, Core Scientific recorded revenue of 115.2 million dollars and gross profit of 30.1 million dollars, equivalent to a gross margin of about 26.1%. By contrast, net profitability remained under severe pressure, as net loss was 347.2 million dollars and loss per share was 1.06 dollars, compared with revenue of 81.1 million dollars, gross profit of 3.9 million dollars, and net loss of 146.7 million dollars in the third quarter of 2025.
In terms of the operating mix, management announced on May 6, 2026 that it had begun billing 243 megawatts of capacity to CoreWeave, equivalent to more than 350 million dollars of annual GAAP hosting revenue. Delivery has been completed at the Marble facility in North Carolina with 65 megawatts and the Dalton Phase I facility in Georgia with 30 megawatts, while the company is targeting more than 450 megawatts billed by the end of the summer and reaching the full 590 megawatts contracted with CoreWeave in early 2027.
The market capitalization provided for Core Scientific is about 6.8 billion dollars, and no positive earnings multiple appears because the company recorded large net losses in the first quarter of 2026 and on a TTM basis. The analyst consensus is Buy, and the average price target is 33.57 dollars with a target range between 29 and 40 dollars; based on the provided 52-week range of 12.42 to 30.46 dollars, the stock is below the average analyst target within this data. Therefore, the valuation reading appears tied to the company’s ability to convert funded and under-construction capacity into contracts, revenue, and margins, not to proven current earnings.
Figures in the text are as of 2026-07-06; the live price is shown at the top of the page.
Core Scientific is transforming into a high-density digital infrastructure company focused on artificial intelligence and high-performance computing. In the May 6, 2026 call, management said it was billing 243 megawatts of capacity to CoreWeave, equivalent to more than 350 million dollars of annual GAAP revenue. Bitcoin mining is no longer the focus of growth, as the company said it will continue to decline through the rest of 2026 and may remain at only one or two sites by year-end. The company has also sold a large portion of its Bitcoin holdings and currently retains only a modest amount on the balance sheet.
The CoreWeave contract is the current financial and operational foundation of Core Scientific’s transformation. The company said it delivered 243 megawatts billed, including 65 megawatts at Marble, North Carolina and 30 megawatts at Dalton Phase I, Georgia. Management is targeting more than 450 megawatts billed by the end of the summer and the full 590 megawatts in early 2027. The contract’s revenue is also recognized on a straight-line basis over a 12-year lease term, making the contract a long-term source of accounting revenue.
The company closed 3.3 billion dollars of project bond financing linked to the CoreWeave contract at 7.75% interest on the day it announced first-quarter 2026 results. Net proceeds after closing costs and the debt service reserve account were about 2.9 billion dollars. Management said the lockbox structure will service the debt backed by the assets and cash flows of the CoreWeave sites, while allowing most of the proceeds to be directed to the corporate level to fund new projects outside that box. This financing supports a capital spending plan of about 2 billion dollars in 2026, including the Hunt County and Muskogee sites and long-lead equipment.
Automated analysis for informational purposes only — not investment advice.
In Pecos, Texas, Core Scientific is converting the site from Bitcoin mining to high-density hosting, and is building an initial facility of 431 thousand square feet with 185 megawatts of power. The company said it has a path to expand Pecos from 300 megawatts to 1.5 gigawatts, with an additional 300 megawatts secured and work underway on grid-connected and behind-the-meter power solutions. In Muskogee, Oklahoma, the company announced a plan to reach 1.5 gigawatts of total power or about 1 gigawatt of leasable capacity. Development of the first 82.5-megawatt building has also begun, with initial delivery expected in the second half of 2027.
Management said the exclusivity period with one hyperscaler on Pecos and Muskogee ended, but explained that three hyperscalers immediately entered active discussions on the two sites. It also said the previous customer remains interested and on the table, indicating continued demand for these assets. In addition to hyperscalers, discussions since the beginning of the year have expanded to chip makers, AI labs, and Neo-cloud providers. However, management explained that some of these emerging categories may need additional credit support to make long-term commitments financeable.
The most prominent financial risk is that operating growth has not yet translated into net profitability, as Core Scientific recorded a net loss of 347.2 million dollars in the first quarter of 2026 and a loss per share of 1.06 dollars. On a TTM basis, revenue was 354.5 million dollars, but the net loss reached 850.0 million dollars. The company also expects capital spending of about 2 billion dollars in 2026, a large figure for a company that is still accounting-loss-making. In addition, insider data show net selling of 3.2 million dollars over three months, with 25 sale transactions and 0 purchase transactions.